31 Critically Ill Patients (Adults)

Friday, March 19, 2010: 12:30 PM-2:00 PM
Grand Hall (Hyatt Regency Atlanta)
Type: Poster
162
Intensive Insulin Therapy for the Prevention of Infection in the Critically Ill: A Meta-analysis of Prospective, Randomized Trials
Matthew Ziegler, University of Wisconsin Madison; Germana Silva, University of Wisconsin Madison; Cybele Abad, University of Wisconsin Madison; Nasia Safdar, University of Wisconsin Madison
163
Multi-drug Resistant Organisms(MDRO) are not an Independent Risk Factor for Mortality in Patients with Pneumonia – The Importance of Adjusting for Comorbidities and Severity of Illness
Anupama Vasudevan, BDS, National University Health System; Douglas Chan, MRCP, National University Health System; Chee Keat Tan, MMed, National University Health System; Amartya Mukhopadhay, MRCP, National University Health System; Paul Ananth Tambyah, MBBS, National University Health System
164
Prevalence and Attributable Mortality of Healthcare-Associated Infections in Patients Who Die in the Hospital
Jeffrey A. Bontrager, MD, Indiana University School of Medicine; Stephen J. Wilson, MD, MPH, Indiana University School of Medicine
165
Antimicrobial Resistance in Intensive Care Units from Seven Brazilian Hospitals
Carlos E.F. Starling, MD, Hospital Vera Cruz; Estevão U. Silva, MD, Hospital Universitário São José and Hospital Vila da Serra; Edna M. Meireles, MD, Hospital Risoleta Tolentino Neves and Hospital da Baleia; Braulio R.G.M. Couto, MSc, Centro Universitário de Belo Horizonte / UNI-BH